Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Language
Publication year range
1.
An Acad Bras Cienc ; 95(2): e20201783, 2023.
Article in English | MEDLINE | ID: mdl-37531490

ABSTRACT

Although widely used in medicine, separation technology, and other fields, the effects of cyclodextrins on the activities of phosphoryl transfer enzymes have not been previously evaluated. In vivo studies evaluated the function of cyclodextrins as active compounds. Despite the use of cyclodextrins as active compounds, the effects of cyclodextrins on hepatic and renal tissues remain to be fully elucidated. The primary objective of this study was to evaluate the effects of ß- cyclodextrins, methyl-ß-cyclodextrin (M-ß- cyclodextrins), and (2-hydroxypropyl)-ß-cyclodextrin (HP-ß-cyclodextrins) on enzyme activities regulating the maintenance of energy homeostasis in the kidney and liver tissues in relation to toxicity. Serum levels of liver and kidney markers were measured, and oxidative stress parameters were assessed. After 60-day treatments, we observed that the administration of ß-cyclodextrins and M-ß-cyclodextrins inhibited the hepatic activity of pyruvate kinase, an irreversible enzyme within the glycolytic pathway. Additionally, administration of HP-ß-cyclodextrins inhibited creatine kinase activity and increased the total sulfhydryl content in kidneys. Here, we demonstrated for the first time that ß-cyclodextrins, M-ß-cyclodextrins, and HP-ß-cyclodextrins cause bioenergetic dysfunction in renal and hepatic tissues. These findings suggest that understanding the balance between cyclodextrins' efficacy and adverse effects is essential for better accepting their use in medicine.


Subject(s)
Cyclodextrins , beta-Cyclodextrins , Rats , Animals , beta-Cyclodextrins/pharmacology , Cyclodextrins/pharmacology , 2-Hydroxypropyl-beta-cyclodextrin/pharmacology , Energy Metabolism
2.
Steroids ; 172: 108861, 2021 08.
Article in English | MEDLINE | ID: mdl-33984388

ABSTRACT

Supraphysiological doses of anabolic-androgenic steroids (AAS) may cause long-term functional abnormalities, particularly in the heart and liver, which may only represent the later-stage of the cumulative damage caused by dysfunctional organelles. We investigated whether mid-term supraphysiological doses of Testosterone and Nandrolone impair mitochondrial Ca2+ and membrane potential (ΔΨm) dynamics, and redox machinery in the heart and liver of mice. CF1 albino mice were treated daily with 15 mg/kg of Nandrolone (ND) or Testosterone (T), or oil (vehicle) for 19 days. Preparations enriched in mitochondria from the heart or liver were used to perform assays of Ca2+ influx/efflux, ΔΨm, and H2O2 production. ND significantly impaired mitochondrial Ca2+ influx in the heart, and ΔΨm in both organs. ND and T increased H2O2 levels in the heart and liver relative to controls. Also, ND increased oxidative damage to lipids and proteins (TBARS and carbonyls) in the heart, and both AAS decreased glutathione peroxidase activity in the heart and liver. In summary, supraphysiological doses of ND, and in a lesser extend T, impaired mitochondrial Ca2+ influx and ΔΨm, and redox homeostasis being early mechanistic substrates for inducing heart and liver tissue damage.


Subject(s)
Anabolic Agents/toxicity , Heart/physiopathology , Liver/pathology , Mitochondria/pathology , Nandrolone/toxicity , Testosterone/toxicity , Androgens/pharmacology , Animals , Heart/drug effects , Liver/drug effects , Male , Mice , Mitochondria/drug effects , Oxidation-Reduction
3.
An Acad Bras Cienc ; 91(3): e20181330, 2019.
Article in English | MEDLINE | ID: mdl-31508665

ABSTRACT

Type 1 diabetes (T1D) is the result of the selective destruction of the pancreatic ß-cells by T cells of the immune system. Although spleen is a secondary lymphoid organ, it is also involved in the T1D pathogenesis. However, the alterations in a variety of cellular processes of this disease need to be further understood. We aimed to analyze the benefits of resveratrol, and its complexed form on diabetic complications in the spleen of rats. To this end, we investigated important enzymes of phosphoryl transfer network, and Na+, K+-ATPase activity. Wistar rats were divided into non-diabetic groups: Control, Ethanol, Resveratrol, Hydroxypropyl-ß-cyclodextrin, Resveratrol-hydroxypropyl-ß-cyclodextrin, and diabetic groups with the same treatments. Diabetes was induced by a single dose of 60 mg/kg of streptozocin intraperitoneally, and treatments by intragastric gavage once daily for 60 days. Hyperglycemia reduced creatine kinase activity, which was reversed by the administration of resveratrol. Na+, K+-ATPase activity was greatly affected, but it was reversed by resveratrol and resveratrol-hydroxypropyl-ß-cyclodextrin. This suggest an energetic imbalance in the spleen of diabetic rats, and in case this also occurs in the diabetic patients, it is possible that resveratrol supplementation could be beneficial to the better functioning of the spleen in diabetic patients.


Subject(s)
2-Hydroxypropyl-beta-cyclodextrin/pharmacology , Antioxidants/pharmacology , Diabetes Mellitus, Experimental/metabolism , Resveratrol/pharmacology , Sodium-Potassium-Exchanging ATPase/metabolism , Spleen/metabolism , Animals , Antioxidants/metabolism , Blood Glucose/analysis , Body Weight , Creatine Kinase/metabolism , Diabetes Mellitus, Experimental/chemically induced , Energy Metabolism/drug effects , Hyperglycemia/metabolism , Male , Organ Size , Rats , Rats, Wistar , Streptozocin
4.
An. acad. bras. ciênc ; 90(1): 99-108, Mar. 2018. graf
Article in English | LILACS | ID: biblio-886876

ABSTRACT

ABSTRACT Considering that thiol-containing enzymes like kinases are critical for several metabolic pathways and energy homeostasis, we investigated the effects of cystine dimethyl ester and/or cysteamine administration on kinases crucial for energy metabolism in the kidney of Wistar rats. Animals were injected twice a day with 1.6 µmol/g body weight cystine dimethyl ester and/or 0.26 µmol/g body weight cysteamine from the 16th to the 20th postpartum day and euthanized after 12 hours. Pyruvate kinase, adenylate kinase, creatine kinase activities and thiol/disulfide ratio were determined. Cystine dimethyl ester administration reduced thiol/disulfide ratio and inhibited the kinases activities. Cysteamine administration increased the thiol/disulfide ratio and co-administration with cystine dimethyl ester prevented the inhibition of the enzymes. Regression between the thiol/disulfide ratio, and the kinases activities were significant. These results suggest that redox status may regulate energy metabolism in the rat kidney. If thiol-containing enzymes inhibition and oxidative stress occur in patients with cystinosis, it is possible that lysosomal cystine depletion may not be the only beneficial effect of cysteamine administration, but also its antioxidant and thiol-protector effect.


Subject(s)
Animals , Sulfhydryl Compounds , Cysteamine/pharmacology , Cystine/analogs & derivatives , Disulfides , Homeostasis/drug effects , Kidney/drug effects , Adenylate Kinase/analysis , Adenylate Kinase/drug effects , Reproducibility of Results , Rats, Wistar , Creatine Kinase/analysis , Creatine Kinase/drug effects , Cystine/pharmacology , Cystine Depleting Agents/pharmacology
5.
An Acad Bras Cienc ; 90(1): 99-108, 2018.
Article in English | MEDLINE | ID: mdl-29236866

ABSTRACT

Considering that thiol-containing enzymes like kinases are critical for several metabolic pathways and energy homeostasis, we investigated the effects of cystine dimethyl ester and/or cysteamine administration on kinases crucial for energy metabolism in the kidney of Wistar rats. Animals were injected twice a day with 1.6 µmol/g body weight cystine dimethyl ester and/or 0.26 µmol/g body weight cysteamine from the 16th to the 20th postpartum day and euthanized after 12 hours. Pyruvate kinase, adenylate kinase, creatine kinase activities and thiol/disulfide ratio were determined. Cystine dimethyl ester administration reduced thiol/disulfide ratio and inhibited the kinases activities. Cysteamine administration increased the thiol/disulfide ratio and co-administration with cystine dimethyl ester prevented the inhibition of the enzymes. Regression between the thiol/disulfide ratio, and the kinases activities were significant. These results suggest that redox status may regulate energy metabolism in the rat kidney. If thiol-containing enzymes inhibition and oxidative stress occur in patients with cystinosis, it is possible that lysosomal cystine depletion may not be the only beneficial effect of cysteamine administration, but also its antioxidant and thiol-protector effect.


Subject(s)
Cysteamine/pharmacology , Cystine/analogs & derivatives , Disulfides , Homeostasis/drug effects , Kidney/drug effects , Sulfhydryl Compounds , Adenylate Kinase/analysis , Adenylate Kinase/drug effects , Animals , Creatine Kinase/analysis , Creatine Kinase/drug effects , Cystine/pharmacology , Cystine Depleting Agents/pharmacology , Kidney/enzymology , Pyruvate Kinase/analysis , Pyruvate Kinase/drug effects , Random Allocation , Rats, Wistar , Reference Values , Reproducibility of Results
SELECTION OF CITATIONS
SEARCH DETAIL
...